Non-enzymatic glycation of human fibrillin-1

Gerontology

Volumn 55, Issue 1, 2009, Pages 73-81

  Atanasova, Milena ^a   Konova, Emiliana ^a   Betova, Tatiana ^a   Baydanoff, Stephan ^a  

^a MEDICAL UNIVERSITY PLEVEN   (Bulgaria)

Author keywords

Advanced glycation end products; Aging process; Fibrillin 1; Non enzymatic glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; FIBRILLIN 1; FRUCTOSAMINE;

ADULT; AGED; ARTICLE; CHILD; COLORIMETRY; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTERMETHOD COMPARISON; NORMAL HUMAN; PH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PROTEIN PURIFICATION; THORACIC AORTA;

ADULT; AGED; AGING; AORTA, THORACIC; CHILD, PRESCHOOL; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; MICROFILAMENT PROTEINS; MIDDLE AGED;

EID: 59749084741     PISSN: 0304324X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000157436     Document Type: Article

References (38)

1. Cerami A: Hypothesis - glucose as a mediator of aging. J Am Geriatr Soc 1985;33:624-634.
2. Trivelli LA, Kanney HM, Lai HT: Hemoglobin components in patients with diabetes mellitus. N Engl J Med 1971;284:353-357.
3. Bunn HF: Structural heterogeneity of human HbA due to nonenzymatic glycosylation. Biol Chem 1979;254:3892-3898.
4. Gopalkrishnapillai B, Nadanathangam V, Karmakar N, Anand S, Mistra A: Evaluation of autofluorescent property of haemoglobin-advanced glycation end products as a long-term glycemic index of diabetes. Diabetes 2003;52:1041-1046.
5. 1b and human serum albumin in a lyophilized glucose formulation. Int J Pharm 2006;28:136-145.
6. Kirstein M, Brett J, Radoff J, et al: Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990;87:9010-9014.
7. Calvo C, Luo BY, Puygranier F, et al: Characterization and metabolism of glycated high density lipoproteins in diabetic patients. Adv Exp Med Biol 1988;243:165-172.
8. Brownless M, Vlassara H, Cerami A: Inhibition of heparin catalysed human antithrombin III activity by nonenzymatic glycosylation: possible role in fibrin deposition in diabetes. Diabetes 1984;33:532-535.
9. Coradello H, Lubee G, Pollack A, Sternberg M: Enzyme activities of native non-enzymatically glycosylated trypsin, chymotrypsin and papain (in German). Padiatr Padol 1982;17:457-464.
10. Dolhofer R, Wicland OH: Preparation and biological properties of glycosylated insulin. FEBS Lett 1979;100:133-136.
11. Lindsay JR, McKillop AM, Mooney MH, Flatt PR, Bell PM, O'Harte FP: Meal-induced 24-hour profile of circulating glycated insulin in type 2 diabetic subjects measured by a novel radioimmunoassay. Metabolism 2003;52:631-635.
12. Schnider SL, Kohn RR: Effects of age and diabetes mellitus on the solubility and nonenzymatic glycosylation of human skin collagen. J Clin Invest 1981;67:1630-1635.
13. Trueb B, Fluckiger R, Winterhalter KH: Nonenzymatic glycosylation of basement membrane collagen in diabetes mellitus. Coll Relat Res 1984;4:239-251.
14. Vishwanath V, Frank K, Elmetes F, et al: Glycation of skin collagen in type 1 diabetes mellitus. Diabetes 1986;35:916-921.
15. Monnier VM, Kohn RR, Cerami A: Accelerated age-related browning of human collagen in diabetes mellitus. Proc Natl Acad Sci USA 1984;81:583-587.
16. Genut S, Sun W, Cleary P, Sell DR, Dahms W, Malone J, Sivitz W, Monnier VM: Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complications participants with type 1 diabetes. Diabetes 2005;54:3103-3111.
17. Stevens VJ, Rouzer CA, Monnier VM, Cerami A: Diabetic cataract formation: potential role of glycosylation of lens crystallins. Proc Natl Acad Sci USA 1978;75:2918-2922.
18. Tarsio JF, Roger LA, Furcht LT: Decreased interaction of fibronectin, type IV collagen and heparin due to nonenzymatic glycation. Implications for diabetes mellitus. Biochemistry 1987;26:1014-1020.
19. Bhatwadekar AD, Glenn JV, Li G, Curtis TM, Gardiner TA, Stitt AW: Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy. Invest Ophthalmol Vis Sci 2008;49:1232-1241.
20. Charsonis AS, Tsilibary EC: Structural and functional changes of laminin and type IV collagen after non-enzymatic glycation. Diabetes 1992;41:49-51.
21. Greene DA: Metabolic abnormalities in diabetic peripheral nerve: relation to impaired function. Metabolism 1980;92:118-123.
22. Dutta U, Cohenford AM, Dain JA: Monitoring the effect of glucosamine and glyceraldehydes glycation on the secondary structure of human serum albumin and immunoglobulin G: an analysis based on circular dichroism, thermal melting profiles and UV-fluorescence spectroscopy. Anal Chim Acta 2006;558:187-194.
23. Sakay LY, Keene DR, Engvall E: Fibrillin, a new 350-kDa glycoprotein, is a component of extracellular microfibrils. J Cell Biol 1986;103:2499-2509.
24. Zhang H, Apfelroth SD, Hu W, Davis EC, Sanguineti C, Bonadio J: Structure and expression of fibrillin-2, a novel microfibrillar component preferentially located in elastic matrices. J Cell Biol 1994;124:855-863.
25. Nagase T, Nakayama M, Nakajima D, Kikuno R, Ohara O: Prediction of the coding sequences of unindentified human genes. XX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 2001;8:85-95.
26. Kielty C, Cummings C, Whittaker S, Shuttleworth A, Grant M: Isolation and ultrastructural analysis of microfibrillar structures from fetal bovine elastic tissues. J Cell Sci 1991;99:797-807.
27. Johnson RN, Metcalf PA, Baker JR: Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control. Clin Chim Acta 1982;127:87-95.
28. McFarland KF, Cataland KF, Day JF, et al: Nonenzymatic glycosylation of serum proteins in diabetes mellitus. Diabetes 1979;28:1011-1014.
29. Baydanoff S, Konova E, Dosheva I, Dorovski P: Non-enzymatic glycation of elastin. Glycosylation Dis 1994;1:53-58.
30. Mecham RP, Davis E: The Elastic Fiber. Extracellular Matrix Assembly and Structure. New York, Academic Press, 1994, pp 281-314.
31. Charbonneau NL, Dzamba BJ, Ono RN, Keene DR, Corson GM, Reinhardt DP, Sakai LY: Fibrillins can co-assemble in fibrils, but fibrillin fibril composition displays cell-specific differences. J Biol Chem 2003;278:2740-2749.
32. Corson GM, Charbonneau NL, Keene DL, Sakai LY: Differential expression of fibrillin-3 adds to microfibril variety in human and avian, but not rodent, connective tissues. Genomics 2004;83:461-472.
33. Fu MX, Knecht KJ, Thorpe SR, Baynes JW: Role of oxygen in cross-linking and chemical modification of collagen by glucose. Diabetes 1992;41:42-48.
34. Vlassara H, Brownlee M, Cerami A: Non-enzymatic glycosylation: role in the pathogenesis of diabetic complications. Clin Chem 1986;32:B37-B41.
35. Kennedy L, Beynos JW: Non-enzymatic glycosylation and the chronic complications of diabetes: an overview. Diabetologia 1984;26:93-98.
36. Bitensky MW, Kowluru A, Kowluru RA: Non-enzymatic glycation and protein recognition; in Baynes JW, Monier VM (eds): The Maillard Reaction in Aging, Diabetes and Nutrition. New York, Liss, 1989, pp 185-204.
37. Konova E, Baydanoff S, Atanasova M, Velkova A: Age-related changes in the glycation of human aortic elastin. Exp Gerontol 2004;39:249-254.
38. Baydanoff S, Konova E, Ivanova N: Determination of anti-AGE antibodies in human serum. Glycoconj J 1996;13:335-339.